2012 - Member of the National Academy of Medicine (NAM)
2008 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
His primary areas of investigation include Immunology, Transplantation, Graft-versus-host disease, Internal medicine and Immune system. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Stem cell. His Cytotoxic T cell research is multidisciplinary, relying on both T cell and Molecular biology.
His Transplantation research integrates issues from Total body irradiation, Histocompatibility, Bone marrow, Transplantation Conditioning and Fludarabine. His Graft-versus-host disease research incorporates themes from Blockade, Hematopoietic stem cell transplantation, Cytokine and Pharmacology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Umbilical cord and Surgery.
His primary areas of study are Immunology, Transplantation, Graft-versus-host disease, T cell and Internal medicine. His Immunology research includes themes of Hematopoietic stem cell transplantation and Stem cell. His biological study deals with issues like Leukemia, which deal with fields such as Myeloid leukemia.
Bruce R. Blazar has included themes like Germinal center and Major histocompatibility complex in his Graft-versus-host disease study. His T cell study combines topics in areas such as Cytotoxic T cell, Cancer research, Antigen and Cell biology. The various areas that he examines in his Internal medicine study include Gastroenterology, Endocrinology, Surgery and Oncology.
Graft-versus-host disease, Transplantation, Immunology, T cell and Cancer research are his primary areas of study. His Graft-versus-host disease research focuses on Gastroenterology and how it connects with Umbilical cord. Bruce R. Blazar has researched Transplantation in several fields, including Haematopoiesis, Stem cell, Clinical trial, Adoptive cell transfer and CD80.
He regularly links together related areas like Hematopoietic stem cell transplantation in his Immunology studies. His T cell study incorporates themes from Cytotoxic T cell, CD8, Cytokine and Cell biology. His research in Cancer research intersects with topics in In vivo, Leukemia, Antigen and Immunotherapy.
Bruce R. Blazar mainly investigates T cell, Cancer research, Cell biology, Immunology and Immune system. The study incorporates disciplines such as CD8, Priming, Innate immune system, Autoimmunity and Immunotherapy in addition to T cell. His Cancer research study integrates concerns from other disciplines, such as Cytotoxic T cell, Receptor, In vivo and Antigen.
His Cell biology research integrates issues from Regulatory T cell, Cell and FOXP3. His Immunology research is multidisciplinary, incorporating elements of Graft-versus-host disease, Hematopoietic stem cell transplantation and Transplantation. Bruce R. Blazar has included themes like Tumor progression, Stem cell, Cytokine and Myeloid-derived Suppressor Cell in his Immune system study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
John E. Wagner;Juliet N. Barker;Todd E. DeFor;K. Scott Baker.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi;Lionel Apetoh;Jenna M. Sullivan;Bruce R. Blazar.
Journal of Experimental Medicine (2010)
The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.
Patricia A. Taylor;Christopher J. Lees;Bruce R. Blazar.
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar.
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Claudio G. Brunstein;Jeffrey S. Miller;Qing Cao;David H. McKenna.
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Ricardo Spielberger;Patrick Stiff;William Bensinger;Teresa Gentile.
The New England Journal of Medicine (2004)
IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells
Matthew A. Burchill;Jianying Yang;Christine Vogtenhuber;Bruce R. Blazar.
Journal of Immunology (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma;Babak Baban;Phillip Chandler;De Yan Hou.
Journal of Clinical Investigation (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: